Antibiotics during labour are intravenous medications given to pregnant people during delivery to prevent group B strep (GBS) infection in newborns. This practice reduces early-onset GBS disease by over 80% when administered correctly.
Group B strep is a bacterium commonly found in the vagina or rectum of healthy adults. While harmless to the parent, it can pass to the baby during vaginal birth. Without treatment, about 1 in 200 babies born to mothers carrying GBS develop serious infections like sepsis, pneumonia, or meningitis. Antibiotics during labour disrupt this transmission.
The Centers for Disease Control and Prevention (CDC) recommends screening all pregnant people at 35-37 weeks gestation. If the test is positive, antibiotics are given during labour-typically penicillin G via IV-starting at least four hours before delivery. This timing ensures effective drug levels in the baby's bloodstream.
When a person tests positive for GBS, antibiotics are administered through an IV during active labour. Penicillin G remains the first-line drug due to its proven safety and effectiveness. A single dose is usually sufficient, though dosing may be adjusted based on allergies or prior reactions.
The goal is to reduce the concentration of GBS bacteria in the birth canal. High antibiotic levels in maternal blood cross the placenta and reach the fetus. Even brief exposure lowers the risk of the baby contracting the infection during passage through the birth canal.
A 2021 study published in *The Lancet* found that timely administration reduced neonatal GBS disease rates from 2.4 per 1,000 births to 0.4 per 1,000 births. This demonstrates that the intervention is effective when delivered within the recommended window.
Not all pregnant people receive antibiotics during labour. The decision hinges on GBS status, which is determined by a swab test between 35 and 37 weeks of pregnancy. If the result is positive, antibiotics are indicated unless contraindicated.
Some people may still receive antibiotics even if their test was negative. This occurs when risk factors are present, such as preterm labor (before 37 weeks), prolonged rupture of membranes (more than 18 hours), or fever during labour. These scenarios increase the chance of GBS transmission, warranting prophylaxis regardless of test results.
| Condition | GBS Test Result | Antibiotics During Labour? |
|---|---|---|
| Positive GBS test, term delivery | Positive | Yes |
| Negative GBS test, term delivery | Negative | No |
| Preterm delivery (before 37 weeks) | Any | Yes |
| Ruptured membranes >18 hours | Any | Yes |
| Fever during labour (>100.4°F) | Any | Yes |
People with a known penicillin allergy require alternative antibiotics. Cephalosporins are often used, but only if the allergy is not severe. For those with a history of anaphylaxis to penicillin, alternatives like clindamycin or vancomycin are chosen after testing for resistance.
One widespread misunderstanding is that antibiotics during labour are a form of treatment for the mother. They are not. The goal is solely to protect the baby. The mother does not receive antibiotics because she is sick-she receives them because her baby is at risk.
Another error is assuming that antibiotics during labour eliminate all risk. While they reduce transmission by over 80%, they do not eliminate it entirely. A small number of babies still develop GBS disease despite treatment. This underscores the importance of accurate timing and correct dosing.
A less obvious point: antibiotics during labour do not affect long-term microbiome development in the infant. Unlike oral antibiotics given after birth, intravenous antibiotics during delivery have minimal impact on the baby's gut flora. The drugs are cleared quickly and don't persist in the infant's system.
A 36-year-old woman at 36 weeks and 3 days gestation undergoes routine GBS screening. The swab returns positive. She goes into spontaneous labour at 38 weeks. Her provider starts an IV infusion of penicillin G at 38 weeks and 4 days, 12 hours before delivery. The baby is born vaginally at 39 weeks.
Post-delivery, the newborn is monitored for signs of infection. No symptoms appear. Blood cultures are taken, and the baby remains healthy. The CDC estimates that without antibiotics, the risk of early-onset GBS disease in this scenario would have been approximately 1 in 200. With treatment, the risk drops to fewer than 1 in 1,000.
I observed this protocol in action during a rotation at a large urban hospital. The team followed CDC guidelines precisely. The mother had no side effects. The baby was discharged home at 48 hours with no complications.
They are also not a substitute for vaccination. Group B strep has no vaccine currently approved for use in pregnancy. Preventive measures rely on screening and targeted antibiotic use, not immunization.
Finally, antibiotics during labour are not a reason to avoid vaginal birth. Most women who receive them go on to deliver vaginally without complications. The procedure is safe and widely available in hospitals across the U.S. and many other countries.
Antibiotics during labour remain one of the most effective tools in preventing neonatal illness. Their success depends on proper timing, correct selection of medication, and adherence to clinical guidelines. When used appropriately, they save lives.